Osmotically balanced, large unilamellar liposomes that enable sustained bupivacaine release for prolonged pain relief in in vivo rat models

Abstract To efficiently prolong analgesic effects, we developed osmotically balanced, large unilamellar liposomes (~ 6 μm in diameter) in which highly concentrated bupivacaine (up to 30 mg/mL) was encapsulated, and their sustained bupivacaine release was highly effective in relieving postoperative p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hyebin Yoo, Jun Seok Park, Seung Soo Oh, Hyun Kang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a3b063f74f824d649d0f2aa8312b2a9f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a3b063f74f824d649d0f2aa8312b2a9f
record_format dspace
spelling oai:doaj.org-article:a3b063f74f824d649d0f2aa8312b2a9f2021-12-02T17:52:41ZOsmotically balanced, large unilamellar liposomes that enable sustained bupivacaine release for prolonged pain relief in in vivo rat models10.1038/s41598-021-91624-22045-2322https://doaj.org/article/a3b063f74f824d649d0f2aa8312b2a9f2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91624-2https://doaj.org/toc/2045-2322Abstract To efficiently prolong analgesic effects, we developed osmotically balanced, large unilamellar liposomes (~ 6 μm in diameter) in which highly concentrated bupivacaine (up to 30 mg/mL) was encapsulated, and their sustained bupivacaine release was highly effective in relieving postoperative pain over 24 h in a rat model. Our reverse-phase evaporation method based on non-toxic alcohol, ethanol, enabled simple and cost-effective production of bupivacaine-loaded liposomes, of which osmotic pressure was readily balanced to improve the structural stability of the enlarged unilamellar liposomes along with extension of their shelf life (> a month). The in vitro release profile verified that the release duration of the bupivacaine-loaded liposomes extended up to 6 days. For the in vivo study, male Sprague–Dawley rats were used for the incisional pain model, simulating postoperative pain, and the mechanical withdrawal threshold (MWT) was measured using a von Frey filament. Compared to the control group that received intraplantar administration of normal saline, the group of liposomal bupivacaine showed that the initially increased MWT gradually decreased up to 24 h, and importantly, the analgesic effect of the liposomal bupivacaine was maintained 6 times longer than that of bupivacaine only, proving the potential of effective long-acting anesthetics.Hyebin YooJun Seok ParkSeung Soo OhHyun KangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hyebin Yoo
Jun Seok Park
Seung Soo Oh
Hyun Kang
Osmotically balanced, large unilamellar liposomes that enable sustained bupivacaine release for prolonged pain relief in in vivo rat models
description Abstract To efficiently prolong analgesic effects, we developed osmotically balanced, large unilamellar liposomes (~ 6 μm in diameter) in which highly concentrated bupivacaine (up to 30 mg/mL) was encapsulated, and their sustained bupivacaine release was highly effective in relieving postoperative pain over 24 h in a rat model. Our reverse-phase evaporation method based on non-toxic alcohol, ethanol, enabled simple and cost-effective production of bupivacaine-loaded liposomes, of which osmotic pressure was readily balanced to improve the structural stability of the enlarged unilamellar liposomes along with extension of their shelf life (> a month). The in vitro release profile verified that the release duration of the bupivacaine-loaded liposomes extended up to 6 days. For the in vivo study, male Sprague–Dawley rats were used for the incisional pain model, simulating postoperative pain, and the mechanical withdrawal threshold (MWT) was measured using a von Frey filament. Compared to the control group that received intraplantar administration of normal saline, the group of liposomal bupivacaine showed that the initially increased MWT gradually decreased up to 24 h, and importantly, the analgesic effect of the liposomal bupivacaine was maintained 6 times longer than that of bupivacaine only, proving the potential of effective long-acting anesthetics.
format article
author Hyebin Yoo
Jun Seok Park
Seung Soo Oh
Hyun Kang
author_facet Hyebin Yoo
Jun Seok Park
Seung Soo Oh
Hyun Kang
author_sort Hyebin Yoo
title Osmotically balanced, large unilamellar liposomes that enable sustained bupivacaine release for prolonged pain relief in in vivo rat models
title_short Osmotically balanced, large unilamellar liposomes that enable sustained bupivacaine release for prolonged pain relief in in vivo rat models
title_full Osmotically balanced, large unilamellar liposomes that enable sustained bupivacaine release for prolonged pain relief in in vivo rat models
title_fullStr Osmotically balanced, large unilamellar liposomes that enable sustained bupivacaine release for prolonged pain relief in in vivo rat models
title_full_unstemmed Osmotically balanced, large unilamellar liposomes that enable sustained bupivacaine release for prolonged pain relief in in vivo rat models
title_sort osmotically balanced, large unilamellar liposomes that enable sustained bupivacaine release for prolonged pain relief in in vivo rat models
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/a3b063f74f824d649d0f2aa8312b2a9f
work_keys_str_mv AT hyebinyoo osmoticallybalancedlargeunilamellarliposomesthatenablesustainedbupivacainereleaseforprolongedpainreliefininvivoratmodels
AT junseokpark osmoticallybalancedlargeunilamellarliposomesthatenablesustainedbupivacainereleaseforprolongedpainreliefininvivoratmodels
AT seungsoooh osmoticallybalancedlargeunilamellarliposomesthatenablesustainedbupivacainereleaseforprolongedpainreliefininvivoratmodels
AT hyunkang osmoticallybalancedlargeunilamellarliposomesthatenablesustainedbupivacainereleaseforprolongedpainreliefininvivoratmodels
_version_ 1718379184118562816